Consolidated Balance Sheet - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Current assets:
Cash and cash equivalents	$ 168	$ 899
Trade accounts and other receivables (net of allowance of $9 at December 31, 2018 and $9 at December 31, 2017)	992	976
Inventories	130	113
Other current assets and deferred charges	174	191
Total current assets	1,464	2,179
Investments	7,821	6,552
Property, plant, and equipment – net	27,504	28,211
Intangible assets – net of accumulated amortization	7,767	8,791
Regulatory assets, deferred charges, and other	746	619
Total assets	45,302	46,352
Current liabilities:
Accounts payable	662	978
Accrued liabilities	1,102	1,167
Long-term debt due within one year	47	501
Total current liabilities	1,811	2,646
Long-term debt	22,367	20,434
Deferred income tax liabilities	1,524	3,147
Regulatory liabilities, deferred income, and other	3,603	3,950
Contingent liabilities and commitments (Note 18)
Preferred Stock (Note 15)	35	0
Stockholders’ equity:
Common stock ($1 par value; 1,470 million shares authorized at December 31, 2018 and 960 million shares authorized at December 31, 2017; 1,245 million shares issued at December 31, 2018 and 861 million shares issued at December 31, 2017)	1,245	861
Capital in excess of par value	24,693	18,508
Retained deficit	(10,002)	(8,434)
Accumulated other comprehensive income (loss)	(270)	(238)
Treasury stock, at cost (35 million shares of common stock)	(1,041)	(1,041)
Total stockholders’ equity	14,660	9,656
Noncontrolling interests in consolidated subsidiaries	1,337	6,519
Total equity	15,997	16,175
Total liabilities and equity	$ 45,302	$ 46,352